Cinzia Pellegrini

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications

Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy.

Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy.

Journal: Leukemia & lymphoma
Published: January 29, 2026

Accuracy of percutaneous ultrasound-guided needle biopsy of abdominal lymph nodes for the diagnosis of malignant disease.

Accuracy of percutaneous ultrasound-guided needle biopsy of abdominal lymph nodes for the diagnosis of malignant disease.

Journal: Oncology letters
Published: January 22, 2026

A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

Journal: American journal of hematology
Published: December 19, 2025

MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-Up.

MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-Up.

Journal: American journal of hematology
Published: December 01, 2025

Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors.

Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors.

Journal: British journal of haematology
Published: November 27, 2025

TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.

TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.

Journal: Hematological oncology
Published: September 02, 2025

Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study.

Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 30, 2025

Ultrasound-guided core needle biopsy of nodular lesions of the spleen in hematology clinical practice.

Ultrasound-guided core needle biopsy of nodular lesions of the spleen in hematology clinical practice.

Journal: The oncologist
Published: April 08, 2025

SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy.

SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy.

Journal: Annals of hematology
Published: March 31, 2025

Epcoritamab injection site skin eruption: a frequent yet unharmful effect due to a local delayed reaction mechanism.

Epcoritamab injection site skin eruption: a frequent yet unharmful effect due to a local delayed reaction mechanism.

Journal: Italian journal of dermatology and venereology
Published: February 25, 2025

Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice.

Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice.

Journal: Annals of hematology
Published: January 03, 2025

Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study.

Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study.

Journal: Blood advances
Published: December 09, 2024
Showing 1-12 of 89

Last Updated: 09/26/2026